NDC 0008-2001-01 - Protonix I.V.
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0008-2001
- Requested NDC
- 0008-2001-01
- Package NDCs from labels
- 0008-2001-01, 0008-2001-25, 0008-2001-10
- Manufacturer
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC
- Effective date
- 2022-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANTOPRAZOLE SODIUM | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Takeda GmbH | Pharmacia & Upjohn Company LLC | 2022-05-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0008-2001-01 | EA - Each | 0008-2001 | ad389b07-7de3-422f-b0ff-7201c7e3a0c0 | 1 | 2014-04-03 |
| 0008-2001-10 | EA - Each | 0008-2001 | bda3bf5d-8674-4692-b11d-f8e080e04d1c | 1 | 2014-04-03 |
| 0008-2001-25 | EA - Each | 0008-2001 | 5d5925d0-ec2a-4b9a-aa1c-c0909dde694b | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PANTOPRAZOLE SODIUM | ACTIVE INGREDIENT | 6871619Q5X | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| PANTOPRAZOLE | ACTIVE MOIETY | D8TST4O562 | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | PROTONIX I.V. (PANTOPRAZOLE SODIUM) INJECTION, POWDER, FOR SOLUTION [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Camber Pharmaceuticals, Inc. | ee6278c0-d8c0-417c-a65c-b522ff76fe44 | 2023-11-02 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole | PANTOPRAZOLE | Dr.Reddy's Laboratories Limited | 564709e8-358f-c185-4ecb-b3849c3fe59c | 2023-08-30 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Mylan Pharmaceuticals Inc. | 56ad5b97-8e5f-48a5-b2ba-a5484b43d018 | 2023-08-15 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM | Sun Pharmaceutical Industries, Inc. | 38353b9e-63bd-47e8-b7cb-b198d1e901f9 | 2023-08-03 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | A-S Medication Solutions | f1eb666a-120d-47fd-8c9f-73cef839294a | 2023-07-31 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Lannett Company, Inc. | e7705bf6-e473-4b9c-bb5d-57e26ffe7b97 | 2023-07-21 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Hikma Pharmaceuticals USA Inc. | 1e102c44-232b-4aaf-b457-2a740c47193a | 2023-07-19 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Hikma Pharmaceuticals USA Inc. | b02f3f85-8f9b-4d06-8eae-73e592626f3e | 2023-07-10 | Warnings, Adverse reactions | 6871619Q5X |
| 7aba49f2-1dc1-49cc-b69c-50aff10c1e95 | 5b5ddedd-d429-41a7-8573-10c3e9ad4e52 | 2023-06-22 | Warnings, Adverse reactions | 5b5ddedd-d429-41a7-8573-10c3e9ad4e52 | ||
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Aphena Pharma Solutions - Tennessee, LLC | c10e9c12-e39d-4b0b-bd4c-10d3e9a4cf34 | 2023-02-17 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | XLCare Pharmaceuticals Inc. | 17468dbf-84b6-4c53-9ad5-341350d2cfab | 2023-01-17 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Aphena Pharma Solutions - Tennessee, LLC | e3f711d8-b9d3-46a6-8bf9-6af1cc77003e | 2022-07-15 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Proficient Rx LP | a03aa46f-9eb5-4cf4-addf-745d94af8261 | 2022-06-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | Proficient Rx LP | a7dc4321-331d-49af-976c-cfd69d0055d9 | 2022-05-02 | Warnings, Adverse reactions | 6871619Q5X |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | 7FLD91C86K |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | 7FLD91C86K |
| Pantoprazole Sodium | PANTOPRAZOLE SODIUM | Novadoz Pharmaceuticals LLC | 1172bc4e-1700-402f-8262-97f05bac0d09 | 2022-03-03 | Warnings, Adverse reactions | 6871619Q5X |
| PANTOPRAZOLE SODIUM | PANTOPRAZOLE | Proficient Rx LP | dce2e97a-cd92-46b9-9444-91739bdcd526 | 2019-11-01 | Warnings, Adverse reactions | 6871619Q5X |
| Pantoprazole Sodium | PANTOPRAZOLE | Proficient Rx LP | 6d03491f-20c6-4878-9741-2e21e221eff2 | 2019-11-01 | Warnings, Adverse reactions | 6871619Q5X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.